Proud to share our latest publication: "miR-181c predicts response to exercise training in #HFpEF" in #EJPC @ESC_Journals
Early stage research, but let me walk you through why this could be relevant for your #HFpEF patients! 🧵

📎https://t.co/yGaxH5hXlx#CardioTwitter pic.twitter.com/hk4wvjOmoz

— Andreas Gevaert (@AndreasGevaert) September 17, 2021

Thanks for buying! There’s still a role for textbooks in diseases where the knowledge is mostly experience. But now we have to start planning the 3rd edition! @mmartinezheart @HCMBeat @SpringerCardio @CSHeartResearch @tikuowens @jodieingles27 @4hcm @moiz_hafiz @AnkurKalraMD https://t.co/eYGDrdN8T5

— Srihari S. Naidu, MD (@SrihariNaiduMD) September 19, 2021

For Patients with Acute MI (STEMI, NSTEMI,ACS) who are found to have IDA but WITHOUT history of Overt GI bleeding
when do you do endoscopic evaluation?#GITwitter #CardioGI #CardioTwitter #IDA

— Kamran Mushtaq (@Doc_Kamran) September 20, 2021

De Novo vs Acute-on-Chronic Presentations of HF-Related Cardiogenic Shock:
Insights from the Critical Care Cardiology Trials Network Registry - Journal of Cardiac Failure @ankeetbhatt @ddbergMD @carlosalviar @loridanielsmd @JamesCFangMD @seanvandiepen
👉https://t.co/NaWDtRKXvw pic.twitter.com/nElrgVfHT9

— Journal of Cardiac Failure (@JCardFail) October 11, 2021

Long-term outcomes and periprocedural safety and efficacy of percutaneous left atrial appendage closure in a United Kingdom tertiary center: An 11-year experience, by @briosa_gala, @pope_mtb and colleagues https://t.co/9sFtdZpIvN

— HeartRhythm (@hrs_journal) October 11, 2021